Cytiva hosted a webinar titled Rethinking protein purification featuring Mark Frost from Cytiva on parallel chromatography and automation.

Public source

Publisher name

Public post

Webinar: Rethinking protein purification ​ Join Mark Frost from Cytiva for an expert‑led session on parallel chromatography and automation. This webinar provides insight…

Log in to read the full post

Company

Cytiva

We envision a world in which access to life-changing therapies transforms human health.

Industry
Biotechnology Research
Location
Global, OO
Company size
5,001–10,000 employees

About Cytiva

Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We're the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health. Visit https://www.cytiva.com/privacy to review our privacy policy.

See more

Latest activity

51 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.